Gastric, Pancreatic, And Intestinal Secretions Flashcards
Pepsinogen function
. Inactive proenzyme secreted by chief cells of gastric mucosa
. In gastric lumen, H (under 5 pH) initially converts pepsinogen into pepsin
. Pepsin can autocatalytically activate more pepsinogen
. Maximally active btw 1.5-2
. At pH of 7, the enzyme is denatured
. Digests 10-20% of dietary protein into peptides
. Most protein enters duodenum intact
. Secretion inc. by ACh, pH under 3 in gastric lumen, and gastrin
Gastric lipase
. Secreted by chief cells of gastric mucosa
. Secreted in active form and digests dietary triglycerides at DAG and 2 FFAs
. Enzyme active at pH 3-8
. Can digest 15% of dietary fat
. Inc. secretion by ACh
Intrinsic factor secretion
. Secreted by parietal cells
. Binds vit. B12 in duodenum and transports it to ileum where it is absorbed
. Same substances that stimulate HCl secretion from parietal cells also stimulate intrinsic factor secretion
Gastric mucosal barrier
. Composed of mucin glycoproteins and water w/ trapped bicarbonate
. Prevent mixing of gastric contents w/ surface mucus cells and mucus neck cells (mechanical protection)
. Slow back-diffusion of luminal H towards enterocytes
. Trap and buffer any luminal H w/ HCO3
. Protect the mucosa from digestion by pepsin
Mucin secretion function
Protects the gastric mucosa from HCl, pepsin, physical damage and bacterial invasion
. Lubricates food to ease its passage through GI tract
. Resists diestion by enzymes
Mucin secretory mechanism
. Surface mucus cells and mucus neck cells secrete mucin
. Exocytosis: continuous secretion of mucins
. Cell exfoliation: cells are replaced every 72 hrs
. Regulation inc. by ACh, Gastrin, and prostaglandins
Bicarbonate in GI tract
. Buffers H that enters the gastric mucosal barrier
. Surface mucus cells and mucus neck cells secrete bicarbonate using HCO3-Cl antiporter in their apical membrane
. Comes from action of the intracellularenzyme CA
. Secretion inc. by prostaglandins, H in gastric lumen, and ACh
Gastric mucosal barrier
. All surface mucus cells and mucus neck cells secrete mucins and HCO3 to form gastric mucosal barrier
Prostaglandins in gastric mucosal barrier
. Maintain healthy barrier (cytoprotection) , dec. H secretion from parietal cells . Inc. mucin secretion . Inc. bicarbonate secretion . Inc. gastric mucosal blood flow
Peptic ulcer disease (PUD)
. Peptic ulcer is a loss of mucosal surface through muscularis mucosa of the esophagus, stomach, or duodenum
. Ulcers caused y imbalance btw aggressive (gastric acid and pepsin) and protective (mucus, bicarbonate, prostaglandins) factors
. Causes: infection w/ H. Pylori bacteria, NSAIDs
. Rare cause: Zollinger-Ellison syndrome (ZES)
H. Pylori
. Responsible for most duodenal (70-90%) and gastric (30-60%) ulcers
. Adheres to and colonized in only gastric-type epithelium
. Duodenal ulcer occurs only when epithelium is already damaged from inflammatory response to low pH and gets reverted back to gastric-type epithelium
. Bacteria response and inflammatory response alters intracellular signaling pathways and promote gene mutations resulting in epithelial cell polarity, adhesion, growth, and migration
. Produces urease that splits urea into ammonia CO2 and H2O
. Ammonia buffers local H and weakens mucosal barrier via damaging mucus cells
Chronic H pylori infections
. W/ pangastritis: most common, results in hypochlorhydria, cytokines act directly on parietal cells to dec. cell mass and inhibit acid secretion
. W/ antral gastririts: hyperchlorhydria due to somatostatin (SS) D cell dysfunction resulting in inc. gastrin and HCl secretions
Gastric ulcer is assoc. w/ ____
. Normal or dec. gastric acid secretion and hypergastrinemia
. Diagnosed via endoscopy w/ biopsy
. Treatment: eradication of H pylori via proton pump inhibitor
Duodenal ulcer is typically assoc. w/ ___
. Duodenal ulcer is typically assoc. w/ hyperchlorhydria
NSAIDs function on GI tract
. Reduce the synthesis of cytoprotective prostaglandins by inhibiting COX 1 in GI
. Directly damage GI enterocytes by disrupting cell membranes and uncoupling mitochondrial oxidative phosphorylation resulting in compromised barrier function
. Dec. gastric mucosal blood flow resulting in cellular hypoxia
. Diagnosed via endoscopy
. Treated w/ COX-2 inhibitor or other meds, reduce H secretion, strengthen gastric mucosal barrier w/ mucosal protective agents (sucralfate or PGE1 analogues)
Zollinger-Ellison Syndrome (ZES)
. Accounts for less than 1% of PUD
. Characterized by severe PUD, H hypersecretion and gastrinomas (gastrin-secreting tumors)
. Present w/ abdominal pain, heartburn, and diarrhea
. Vit. B12 malabsorption
. 25% have MEN-1 an autosomal dominant disorder w/ endocrine tumors, pituitary adenoma, and hyperparathyroidosm
. Release of gastrin from G cells will be greatly above normal